Aerin Medical Launches Next-Gen Device to Treat Chronic Rhinitis
Aerin Medical announced the launch of its next-generation RhinAer device for treating chronic rhinitis.
The company, based in Mountain View, California, also announced that UnitedHealthcare's Medicare Advantage policy now covers RhinAer for the treatment of the posterior nasal nerve, effective immediately.
RhinAer+ Device Features
The RhinAer+ device is a temperature- and impedance-controlled radiofrequency device that treats the posterior nasal nerve (PNN) and targets multiple anatomic contributors to chronic rhinitis.
- Features a stylus to enhance procedural efficiency and patient comfort
- Atraumatic tip for improved access and visibility
- Reinforced, malleable shaft for tactile feel and support in challenging anatomy
- Ergonomic handle for control in bilateral treatment
Aerin Medical's new device launch comes over three years after the company launched a previous version of the RhinAer stylus.
Author's summary: Aerin Medical launches next-gen RhinAer device.
More News
- Fitting Place for the Bible in Public Schooling
- Ceasefires in Gaza and Lebanon both favor Israel
- Leading in the Age of Screenshots and Shares
- Movember: 'There is relief once you reach out for help' - news - Western People
- Political Violence Is Distorting American Lawmaking
- Hodgson’s minerals announcements will help Canada set the pace we…
- Joburg's water woes: Residents, civil society to stage protest outside city council chambers
- Can the World Health Organization still be the World’s health conscience? -1 | The cracks in global trust
- Reconstruction State Constitutional Conventions and the Rebirth of American Schooling | Yale Law Journal